Product · #19 of 27 · multi-symptom
Kindra MenoRelief
Capsule from Kindra, made by Kindra. Daily serving: 1 capsule.
Last updated · Price and ratings checked Nov 19, 2026
In short: Kindra MenoRelief scores 48.1/100 in our ranking (#19 of 27). It costs $1.30 a day at the regular price. Evidence: Pycnogenol 100 mg + maca; best ingredient grade C (Pycnogenol (pine bark)). No NSF registry listing was confirmed.
Pros
- None stood out.
Cons
- No NSF registry listing confirmed (the brand says it is third-party tested).
Flags
None found
Score breakdown
Full label: what's in it
| Ingredient (as labeled) | Per day | Evidence page |
|---|---|---|
| Pycnogenol French maritime pine bark extract | 100 mg | Pycnogenol (pine bark) C |
| Maca root powder | 500 mg | Maca C- |
Kindra also sells Core ($47; Pycnogenol + ashwagandha), which is not included here.
Evidence
Our evidence score: 21/40, because: Pycnogenol 100 mg + maca.
Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.
Ingredient evidence
- Pycnogenol (pine bark) C (100 mg here)
Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*. The Menopause Society 2023: Not assessed. - Maca C- (500 mg here)
Maca is an Andean root food studied in a few small trials for mood and libido during menopause*. The trials were too few and too small to be conclusive. The Menopause Society 2023: Not recommended (Level II).
Studies
Studies on its ingredients (4)
-
Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.
170 Japanese women took a low dose of French maritime pine bark extract (60 mg a day) or placebo for 12 weeks. Symptoms, especially hot flashes and sleep, improved more than placebo, though placebo also helped a lot.
- Who
- 170 perimenopausal women (Japan)
- Dose
- Pycnogenol 30 mg twice daily
- Duration
- 12 weeks
- Result
- Kupperman -56% vs -39% placebo (P<.05); hot flashes and sleep improved.
- Funding
- Not stated in abstract (Horphag Research, maker, typically supports Pycnogenol trials; not verified). Funding not stated
-
A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.
About 200 Taiwanese women took 200 mg pine bark extract or placebo for 6 months, and symptoms improved more with the extract.
- Who
- 200 enrolled, 155 completed (Taiwan)
- Dose
- Pycnogenol 200 mg/day
- Duration
- 6 months
- Result
- All climacteric symptoms improved vs placebo; antioxidant status improved.
- Funding
- Not stated in abstract. Funding not stated
-
Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review.
A review found only 4 small trials of maca for menopause; all were positive but too weak to be convincing.
- Who
- 4 RCTs
- Dose
- maca, various
- Duration
- various
- Result
- All 4 showed favorable effects, but trials were few, small and of limited quality.
- Funding
- Academic (Korea/UK). Independent / academic
-
Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.
14 women took maca powder (3.5 g a day) and placebo for 6 weeks each. Mood and sexual-function scores improved on maca without changing hormones. Very small.
- Who
- 14 postmenopausal women (crossover)
- Dose
- maca 3.5 g/day
- Duration
- 6 weeks each arm
- Result
- Lower anxiety, depression and sexual-dysfunction scores vs placebo; no hormone changes.
- Funding
- Not stated in abstract. Funding not stated
The Menopause Society's 2023 statement is in the study library.
Price
| Regular one-time price | $39.00 (30 units, 30 days at label dose) |
|---|---|
| Cost per day | $1.30 |
| Subscription | not shown |
| Price notes | 90 caps $99 (compare-at $117) |
| In stock when checked | Yes |
| Checked | Nov 19, 2026 |
Ratings
Amazon: No Amazon rating
Brand site: no average shown, 389 reviews on ourkindra.com (checked Nov 19, 2026). Brand-site reviews are moderated by the brand.
Star ratings reflect buyer satisfaction, not clinical effect.
Certifications and claims
Verified in a public registry
- No registry listing found.
Claims made by the brand
- “3rd-party tested (every batch: microbes, heavy metals, purity, potency)” Brand claim
- “cGMP-certified, FDA-registered facilities” Brand claim
- “vegan” Brand claim
- “gluten-free” Brand claim
- “non-GMO” Brand claim
- “estrogen-free” Brand claim
Registry check: NSF/ANSI 173 ('Kindra'): not found
Who's behind it
| Brand | Kindra |
|---|---|
| Owner / company | Kindra (ourkindra.com), US femtech brand. |
| Founders | Not stated on the pages we read. |
| Where it's made | Made in the USA (brand claim). Brand claim |
| Medical advisors named |
|
| Source | ourkindra.com |
Flags & safety
Legal, regulatory and quality flags
- Not sold on Amazon (2026-11-19).
Ingredient safety notes
- Pycnogenol (pine bark): Well tolerated in trials.
- Maca: Generally food-safe; no estrogenic activity in vivo.
Not verified
- “3rd-party tested” claim (no public registry listing found). Unverified
Sources
Talk to a clinician first
The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).
If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.